Brand name : PRANLUKAST CAPSULES 112.5 mg "TOWA"
Active ingredient: Pranlukast hydrate
Dosage form: white to yellowish white cupsule, total length 14.2mm
Print on wrapping: Tw429, プランルカスト「トーワ」, 112.5mg
Effects of this medicine
This medicine suppresses by antagonizing leukotriene receptors, leading to improvements in asthmatic symptoms, such as cough, difficulty breathing and allergic reactions such as rhinitis.
It is usually used to allergic rhinitis. This medicine is not intended to stop asthmatic attacks that have already started, but used to prevent these attacks.
Before using this medicine, be sure to tell your doctor and pharmacist
•If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
•If you are pregnant or breastfeeding.
•If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Dosing schedule (How to take this medicine)
•Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>>
•In general, for adults, take 2 capsules (225 mg of the active ingredient) twice a day, after breakfast and dinner. Strictly follow the instructions of your doctor or pharmacist.
•If you miss a dose, take a dose as soon as possible. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. You should never take two doses at one time.
•If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
•Do not stop taking this medicine unless your doctor instructs you to do so.
Precautions while taking this medicine
• Possible adverse reactions to this medicine
The most commonly reported adverse reactions include nausea, diarrhea, abdomen pain, stomach discomfort, headache, sleepiness, dizziness, rash, itch, hives, erythema multiforme exudativum. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
•decreased blood pressure, breathing difficulty, rash[shock, anaphylactoid symptoms]
•bleeding tendency such as purpura, nasal bleeding, gum bleeding[thrombocytopenia]
•general malaise, loss of appetite, yellow discoloration of the skin and the conjunctiva[hepatic dysfunction]
•fever, dry cough, breathing difficulty[leukopenia, interstitial pneumonia, eosinophilic pneumonia]
•muscle pain, feeling of weakness, reddish brown urine[rhabdomyolysis]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
Storage conditions and other information
•Keep out of the reach of children. Store away from direct sunlight, heat and moisture.
•Discard the remainder. Do not store them.
Revised: 9/2009
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. |
